Trelagliptin
99%
- Product Code: 103376
CAS:
865759-25-7
| Molecular Weight: | 357.38 g./mol | Molecular Formula: | C₁₈H₂₀FN₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Trelagliptin is primarily used in the treatment of type 2 diabetes. It works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which helps to increase the levels of incretin hormones in the body. These hormones are responsible for regulating blood glucose levels by stimulating insulin release and reducing the production of glucagon.
The key advantage of Trelagliptin is its long-lasting effect, allowing for once-weekly dosing. This improves patient compliance and convenience compared to other DPP-4 inhibitors that require daily administration. It is often prescribed as part of a comprehensive diabetes management plan, which may include diet, exercise, and other medications.
Trelagliptin is particularly beneficial for patients who struggle with maintaining consistent blood sugar levels or those who prefer a less frequent dosing schedule. It is generally well-tolerated, with a lower risk of hypoglycemia compared to some other antidiabetic drugs. However, it is important to monitor kidney function, as dosage adjustments may be necessary for patients with renal impairment.
Overall, Trelagliptin provides an effective and convenient option for managing type 2 diabetes, helping patients achieve better glycemic control with fewer daily medication doses.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿8,890.00 |
+
-
|
| 0.050 | 10-20 days | ฿42,000.00 |
+
-
|
| 0.100 | 10-20 days | ฿69,000.00 |
+
-
|
Trelagliptin
Trelagliptin is primarily used in the treatment of type 2 diabetes. It works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which helps to increase the levels of incretin hormones in the body. These hormones are responsible for regulating blood glucose levels by stimulating insulin release and reducing the production of glucagon.
The key advantage of Trelagliptin is its long-lasting effect, allowing for once-weekly dosing. This improves patient compliance and convenience compared to other DPP-4 inhibitors that require daily administration. It is often prescribed as part of a comprehensive diabetes management plan, which may include diet, exercise, and other medications.
Trelagliptin is particularly beneficial for patients who struggle with maintaining consistent blood sugar levels or those who prefer a less frequent dosing schedule. It is generally well-tolerated, with a lower risk of hypoglycemia compared to some other antidiabetic drugs. However, it is important to monitor kidney function, as dosage adjustments may be necessary for patients with renal impairment.
Overall, Trelagliptin provides an effective and convenient option for managing type 2 diabetes, helping patients achieve better glycemic control with fewer daily medication doses.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :